Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Privia Health (PRVA) Depreciation & Amortization - Total (2020 - 2025)

Historic Depreciation & Amortization - Total for Privia Health (PRVA) over the last 6 years, with Q3 2025 value amounting to $165000.0.

  • Privia Health's Depreciation & Amortization - Total fell 4329.9% to $165000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $808000.0, marking a year-over-year decrease of 3105.8%. This contributed to the annual value of $1.1 million for FY2024, which is 596.25% down from last year.
  • As of Q3 2025, Privia Health's Depreciation & Amortization - Total stood at $165000.0, which was down 4329.9% from $187000.0 recorded in Q2 2025.
  • Privia Health's Depreciation & Amortization - Total's 5-year high stood at $312000.0 during Q3 2022, with a 5-year trough of $165000.0 in Q3 2025.
  • For the 5-year period, Privia Health's Depreciation & Amortization - Total averaged around $275263.2, with its median value being $291000.0 (2023).
  • Per our database at Business Quant, Privia Health's Depreciation & Amortization - Total surged by 7168.67% in 2021 and then plummeted by 4329.9% in 2025.
  • Quarter analysis of 5 years shows Privia Health's Depreciation & Amortization - Total stood at $283000.0 in 2021, then rose by 3.53% to $293000.0 in 2022, then grew by 1.02% to $296000.0 in 2023, then decreased by 22.97% to $228000.0 in 2024, then decreased by 27.63% to $165000.0 in 2025.
  • Its last three reported values are $165000.0 in Q3 2025, $187000.0 for Q2 2025, and $228000.0 during Q1 2025.